Tropicamide/phenylephrine

Tropicamide/phenylephrine, sold under the brand name Mydcombi is a fixed dose combination of tropicamide and phenylephrine used to dilate the eyes (mydriasis).

Uses your system voice; voice and rate in settings.

≈ 1 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Tropicamide/phenylephrine, sold under the brand name Mydcombi is a fixed dose combination of tropicamide and phenylephrine used to dilate the eyes (mydriasis). It contains, tropicamide, an anticholinergic, and phenylephrine, as the hydrochloride, an alpha-1 adrenergic receptor agonist. It is sprayed into the eyes. It was approved for medical use in the United States in May 2023.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1331685563 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001331685563 · captured 2026-01-07 · ledger · version history

Cite this page as: encyclopegia.org, “Tropicamide/phenylephrine”, snapshot enwiki-001331685563. https://encyclopegia.org/a/tropicamide-phenylephrine

Sources cited in this revision

3 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.